Andrea L. Frohning

CIK 1591945 · View on SEC EDGAR ↗

Insider

First SEC filing: March 6, 2026 · Latest: March 6, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 56 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 7, 2026 XRAY F 802 $12.12 $9,720 63,191 Direct -1.25% Disposed -10.5% (price as of 2026-08-21)
March 4, 2026 XRAY A 121,600 121,600 Direct Acquired (price as of 2026-08-21)
March 4, 2026 XRAY A 26,786 63,992 Direct +71.99% Acquired (price as of 2026-08-21)
March 4, 2026 XRAY F 690 $13.44 $9,274 37,206 Direct -1.82% Disposed -19.3% (price as of 2026-08-21)
March 3, 2026 XRAY F 1,977 $13.30 $26,294 37,896 Direct -4.96% Disposed -18.4% (price as of 2026-08-21)
March 3, 2026 XRAY F 2,990 $13.30 $39,767 39,873 Direct -6.98% Disposed -18.4% (price as of 2026-08-21)
March 2, 2026 XRAY A 8,861 42,863 Direct +26.06% Acquired (price as of 2026-08-21)
Jan. 9, 2026 XRAY A 23 $12.22 $281 1,759 Direct +1.32% Acquired -11.2% (price as of 2026-08-21)
Jan. 9, 2026 XRAY A 392 34,002 Direct +1.17% Acquired (price as of 2026-08-21)
Oct. 10, 2025 XRAY A 23 $11.98 $276 1,737 Direct +1.34% Acquired -9.4% (price as of 2026-08-21)
Oct. 10, 2025 XRAY A 357 33,610 Direct +1.07% Acquired (price as of 2026-08-21)
Aug. 8, 2025 XRAY F 788 $12.96 $10,212 33,253 Direct -2.31% Disposed -16.3% (price as of 2026-08-21)
July 11, 2025 XRAY A 17 $16.20 $275 1,714 Direct +1.00% Acquired -33.0% (price as of 2026-08-21)
July 11, 2025 XRAY A 305 34,041 Direct +0.90% Acquired (price as of 2026-08-21)
April 11, 2025 XRAY A 21 $12.47 $262 1,697 Direct +1.25% Acquired -13.0% (price as of 2026-08-21)
April 11, 2025 XRAY A 322 $1.00 $322 33,736 Direct +0.96% Acquired 985.0% (price as of 2026-08-21)
March 4, 2025 XRAY F 792 $15.59 $12,347 33,415 Direct -2.32% Disposed -30.4% (price as of 2026-08-21)
March 3, 2025 XRAY A 207,500 207,500 Direct Acquired (price as of 2026-08-21)
March 3, 2025 XRAY A 20,013 34,207 Direct +141.00% Acquired (price as of 2026-08-21)
Jan. 10, 2025 XRAY A 14 $18.51 $259 1,675 Direct +0.84% Acquired -41.4% (price as of 2026-08-21)
Jan. 10, 2025 XRAY A 103 14,194 Direct +0.73% Acquired (price as of 2026-08-21)
Oct. 11, 2024 XRAY A 11 $24.50 $270 1,661 Direct +0.67% Acquired -55.7% (price as of 2026-08-21)
Oct. 11, 2024 XRAY A 72 14,090 Direct +0.51% Acquired (price as of 2026-08-21)
Aug. 9, 2024 XRAY F 768 $24.13 $18,532 14,019 Direct -5.19% Disposed -55.0% (price as of 2026-08-21)
July 12, 2024 XRAY A 10 $25.80 $258 1,650 Direct +0.61% Acquired -57.9% (price as of 2026-08-21)
July 12, 2024 XRAY A 94 14,787 Direct +0.64% Acquired (price as of 2026-08-21)
April 12, 2024 XRAY A 8 $31.45 $252 1,640 Direct +0.49% Acquired -65.5% (price as of 2026-08-21)
April 12, 2024 XRAY A 70 14,692 Direct +0.48% Acquired (price as of 2026-08-21)
March 18, 2024 XRAY A 1,632 $35.59 $58,083 1,632 Direct Acquired -69.5% (price as of 2026-08-21)
March 4, 2024 XRAY A 22,600 22,600 Direct Acquired (price as of 2026-08-21)
March 4, 2024 XRAY A 6,761 14,622 Direct +86.01% Acquired (price as of 2026-08-21)
Jan. 12, 2024 XRAY A 31 7,861 Direct +0.40% Acquired (price as of 2026-08-21)
Oct. 13, 2023 XRAY A 32 7,830 Direct +0.41% Acquired (price as of 2026-08-21)
Aug. 9, 2023 XRAY A 24,500 24,500 Direct Acquired (price as of 2026-08-21)
Aug. 9, 2023 XRAY A 7,798 7,798 Direct Acquired (price as of 2026-08-21)
Jan. 26, 2016 CXT M 288 2,424 Direct -10.62% Disposed (price as of 2026-08-21)
Jan. 26, 2016 CXT F 113 $46.52 $5,257 805 Direct -12.31% Disposed 211.1% (price as of 2026-08-21)
Jan. 26, 2016 CXT M 288 918 Direct +45.71% Acquired (price as of 2026-08-21)
Dec. 9, 2015 CXT M 345 2,712 Direct -11.29% Disposed (price as of 2026-08-21)
Dec. 9, 2015 CXT F 117 $48.63 $5,690 630 Direct -15.66% Disposed 197.6% (price as of 2026-08-21)
Dec. 9, 2015 CXT M 345 747 Direct +85.82% Acquired (price as of 2026-08-21)
Jan. 27, 2015 CXT M 289 3,057 Direct -8.64% Disposed (price as of 2026-08-21)
Jan. 27, 2015 CXT F 114 $58.82 $6,705 402 Direct -22.09% Disposed 146.1% (price as of 2026-08-21)
Jan. 27, 2015 CXT M 289 516 Direct +127.31% Acquired (price as of 2026-08-21)
Jan. 26, 2015 CXT A 1,154 3,346 Direct +52.65% Acquired (price as of 2026-08-21)
Jan. 26, 2015 CXT A 15,974 15,974 Direct Acquired (price as of 2026-08-21)
Jan. 26, 2015 CXT A 3,682 3,682 Direct Acquired (price as of 2026-08-21)
Dec. 9, 2014 CXT M 344 2,192 Direct -13.56% Disposed (price as of 2026-08-21)
Dec. 9, 2014 CXT J 48 48 Indirect Acquired (price as of 2026-08-21)
Dec. 9, 2014 CXT F 117 $57.72 $6,753 227 Direct -34.01% Disposed 150.7% (price as of 2026-08-21)
Dec. 9, 2014 CXT M 344 344 Direct Acquired (price as of 2026-08-21)
Jan. 27, 2014 CXT A 1,158 2,536 Direct +84.03% Acquired (price as of 2026-08-21)
Jan. 27, 2014 CXT A 13,922 13,922 Direct Acquired (price as of 2026-08-21)
Jan. 27, 2014 CXT A 4,088 4,088 Direct Acquired (price as of 2026-08-21)
Dec. 9, 2013 CXT A 1,378 1,378 Direct Acquired (price as of 2026-08-21)
Dec. 9, 2013 CXT A 10,290 10,290 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 4, 2026 XRAY Stock Option (Right to Buy) Common Stock (121,600) $14.78 March 4, 2036 121,600 Acquired
Jan. 9, 2026 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (23) 23 Acquired
Oct. 10, 2025 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (23) 23 Acquired
July 11, 2025 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (17) 17 Acquired
April 11, 2025 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (21) 21 Acquired
March 3, 2025 XRAY Stock Option (Right to Buy) Common Stock (207,500) $15.99 March 3, 2035 207,500 Acquired
Jan. 10, 2025 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (14) 14 Acquired
Oct. 11, 2024 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (11) 11 Acquired
July 12, 2024 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (10) 10 Acquired
April 12, 2024 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (8) 8 Acquired
March 18, 2024 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (1,632) 1,632 Acquired
March 4, 2024 XRAY Stock Option (Right to Buy) Common Stock (22,600) $33.28 March 4, 2034 22,600 Acquired
Aug. 9, 2023 XRAY Stock Option (Right to Buy) Common Stock (24,500) $38.47 Aug. 9, 2033 24,500 Acquired
Jan. 26, 2016 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (288) 288 Disposed
Dec. 9, 2015 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (345) 345 Disposed
Jan. 27, 2015 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (289) 289 Disposed
Jan. 26, 2015 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (1,154) 1,154 Acquired
Jan. 26, 2015 CXT Employee Stock Option (Right to Buy) CRANE CO. COMMON, PAR VALUE $1.00 (15,974) $58.47 Jan. 26, 2025 15,974 Acquired
Jan. 26, 2015 CXT 2015 Performance-Based Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (3,682) 3,682 Acquired
Dec. 9, 2014 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (344) 344 Disposed
Jan. 27, 2014 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (1,158) 1,158 Acquired
Jan. 27, 2014 CXT Employee Stock Option (Right to Buy) CRANE CO. COMMON, PAR VALUE $1.00 (13,922) $64.78 Jan. 27, 2024 13,922 Acquired
Jan. 27, 2014 CXT 2014 Performance-Based Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (4,088) 4,088 Acquired
Dec. 9, 2013 CXT Restricted Share Unit CRANE CO. COMMON, PAR VALUE $1.00 (1,378) 1,378 Acquired
Dec. 9, 2013 CXT Employee Stock Option (Right to Buy) CRANE CO. COMMON, PAR VALUE $1.00 (10,290) $65.30 Dec. 9, 2019 10,290 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).